Navigation Links
Founder of Curidium Launches Elixior, an Advisory Company Focused on the Development and Growth of Innovative Personalized Medicine Businesses
Date:9/6/2009

LONDON, September 7 /PRNewswire/ -- Elixior Limited, the advisory company focused on the development and growth of innovative personalized medicine businesses, announced today its launch by the founder and former CEO of Curidium, Dr Anne Bruinvels.

    Elixior's business activities are aimed at:

    - Supporting the development and growth of personalized medicine
      businesses through the creation of partnerships and / or the sourcing
      of investments

    - Helping personalized medicine companies with the structuring of their
      corporate and commercial strategies

    - Conducting due diligence on personalized medicine ventures

    - Building a world-wide, personalized medicine knowledge-base to support
    cooperation between personalized medicine businesses and the growth of
    the sector.

Dr Anne Bruinvels, founder and CEO of Elixior, commented: "The field of personalized medicine is moving forward rapidly and it is Elixior's aim to help the development and commercialization of new innovations in this exciting area. Personalized medicine has the potential to treat patients more effectively and to make healthcare much more cost-effective over time. I look forward to working with small and big companies alike planning to move into or expand in this field."

Previously, Dr Anne Bruinvels founded Curidium, a personalized medicine company focused on improving the diagnosis and treatment of central nervous system disorders. She was Curidium's CEO for more than six years, during which she took the company public on the AIM of the London Stock Exchange.

About Personalized Medicine

The term personalized medicine means the use of molecular analysis methods to better manage a patient's disease or disease predisposition. These methods include testing for variations in genes, gene expression, proteins, and metabolites. Test results are correlated with clinical factors-such as drug response, disease state, and treatment prognosis-and help physicians individualize treatment for each patient.

Further information on Elixior can be found at the Company's website: http://www.elixior.com. or further information, please contact:

    Anne Bruinvels, CEO
    Phone: +44(0)77-67-807-865
    E-mail: anne.bruinvels@elixior.com



'/>"/>
SOURCE Elixior Limited
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Kenneth G. Langone, Home Depot Co-Founder, Chairman of the NYU Langone Medical Center, to Lead 65th Annual Columbus Day Parade as Grand Marshal
2. Laurence Barsh, DMD, Founder of Snoring Isn't Sexy, LLC Emphasizes Need to Evaluate and Treat Sleep Patients
3. AMERIGROUP Foundation Honors Warehouse of Hope Founder Craig Parson as a Healthy Hero
4. Laurence I. Barsh, DMD, Founder of Snoring Isn't Sexy, to speak at Somnomed's First Annual Symposium
5. Randall Terry, Founder, Operation Rescue: Abortion, Healthcare, and Social Upheaval: Pro-life Leaders to Discuss Backlash -- Including Potential of Unwanted Violence
6. Miles To End Malaria Program Gets an Extra Burst of Speed From American Le Mans Series Founder Don Panoz
7. Founders of Running Skirts Inc. Set to Launch New Maternity Line
8. Founder and CEO of HealthTech, Molly Coye, MD, Assumes Leadership of CalRHIO
9. Angelo Masciantonio, CEO and Co-Founder of HTH Worldwide Named Ernst & Young 2009 Entrepreneur Of The Year(R) in Greater Philadelphia
10. Chopra Center Co-Founder and Best-Selling Author David Simon, M.D., Will Lead Two Special Events in New York City This June
11. Medeguide Founder to Lead Online Healthcare Marketing Workshop at the Healthcare Travel Conference in Singapore
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at a ... to wait until March 2017 for an interest rate increase, according to Rajeev Dhawan ... Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest to ...
(Date:5/26/2016)... St. Louis, Missouri (PRWEB) , ... May 26, ... ... optimal cost, quality and clinical outcomes, hosted members and suppliers for its inaugural ... with a focus on their mission of elevating the operational health of America’s ...
(Date:5/26/2016)... ... 26, 2016 , ... The Woodlands at John Knox Village , Florida’s ... care for living and healing, celebrated its grand opening, today. The Woodlands at John ... provided by Empowered Staff. , “This is an incredibly fulfilling time for John Knox ...
(Date:5/26/2016)... N.J. (PRWEB) , ... May 26, 2016 , ... ... delivery technologies and development solutions for drugs, biologics, consumer health and global clinical ... sales office in Korea to support the company’s continued investment and strategic growth ...
(Date:5/26/2016)... ... , ... Memorial Day Weekend marks the unofficial start of summer and the ... make sure your family and vehicle are ready to hit the road this weekend. ... deaths and an additional 50,500 serious injuries from motor vehicle crashes during the three-day ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , May 25, 2016  Zymo Research Corp. ... their new reference materials that help researchers obtain ... collection to analyses. The rapid growth of the ... researchers to have standard methods to improve the ... Biases inherently exist at every step of the ...
(Date:5/25/2016)... May 25, 2016  Granger Diagnostics today announced immediate ... wounds and infections. This test ensures discovery of ... viruses. The test requires only a simple swab of ... David G. Bostwick , MD, Chief Medical ... wound healing: "We are excited to make available, ...
(Date:5/25/2016)... , May 25, 2016 ... H1 2016"market research report that provides an overview ... comparative analysis at various stages, therapeutics assessment by ... administration (RoA) and molecule type, along with latest ... also reviews key players involved in the therapeutic ...
Breaking Medicine Technology: